首页> 美国卫生研究院文献>Molecular Cellular Proteomics : MCP >Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers
【2h】

Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers

机译:用蛋白质组学和基因组生物标志物评估年龄相关性黄斑变性的易感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Age-related macular degeneration (AMD) is a progressive disease and major cause of severe visual loss. Toward the discovery of tools for early identification of AMD susceptibility, we evaluated the combined predictive capability of proteomic and genomic AMD biomarkers. We quantified plasma carboxyethylpyrrole (CEP) oxidative protein modifications and CEP autoantibodies by ELISA in 916 AMD and 488 control donors. CEP adducts are uniquely generated from oxidation of docosahexaenoate-containing lipids that are abundant in the retina. Mean CEP adduct and autoantibody levels were found to be elevated in AMD plasma by ∼60 and ∼30%, respectively. The odds ratio for both CEP markers elevated was 3-fold greater or more in AMD than in control patients. Genotyping was performed for AMD risk polymorphisms associated with age-related maculopathy susceptibility 2 (ARMS2), high temperature requirement factor A1 (HTRA1), complement factor H, and complement C3, and the risk of AMD was predicted based on genotype alone or in combination with the CEP markers. The AMD risk predicted for those exhibiting elevated CEP markers and risk genotypes was 2–3-fold greater than the risk based on genotype alone. AMD donors carrying the ARMS2 and HTRA1 risk alleles were the most likely to exhibit elevated CEP markers. The results compellingly demonstrate higher mean CEP marker levels in AMD plasma over a broad age range. Receiver operating characteristic curves suggest that CEP markers alone can discriminate between AMD and control plasma donors with ∼76% accuracy and in combination with genomic markers provide up to ∼80% discrimination accuracy. Plasma CEP marker levels were altered slightly by several demographic and health factors that warrant further study. We conclude that CEP plasma biomarkers, particularly in combination with genomic markers, offer a potential early warning system for assessing susceptibility to this blinding, multifactorial disease.
机译:年龄相关性黄斑变性(AMD)是一种进行性疾病,是严重视力丧失的主要原因。为了发现早期识别AMD易感性的工具,我们评估了蛋白质组学和基因组AMD生物标志物的组合预测能力。我们在916个AMD和488个对照供体中通过ELISA定量了血浆羧乙基吡咯(CEP)氧化蛋白修饰和CEP自身抗体。 CEP加合物是由视网膜中富含二十二碳六烯酸酯的脂质氧化而成的。发现AMD血浆中的平均CEP加合物和自身抗体水平分别升高了约60%和约30%。与对照组相比,AMD中两种CEP标记升高的优势比是3倍以上。对与年龄相关性黄斑病易感性2(ARMS2),高温需求因子A1(HTRA1),补体因子H和补体C3相关的AMD风险多态性进行基因分型,并根据基因型单独或组合预测了AMD的风险与CEP标记。 CEP标志物和风险基因型升高的人预测的AMD风险比仅基于基因型的风险高2-3倍。携带ARMS2和HTRA1风险等位基因的AMD供体最有可能表现出升高的CEP标记。结果令人信服地证明,在较宽的年龄范围内,AMD血浆中的平均CEP标记水平更高。接收器工作特征曲线表明,单独的CEP标记可以以约76%的准确度区分AMD和对照血浆供体,并与基因组标记结合使用可提供高达约80%的识别准确度。血浆CEP标记物水平因若干人口统计学和健康因素而略有改变,值得进一步研究。我们得出的结论是,CEP血浆生物标志物,特别是与基因组标志物组合,可提供潜在的预警系统,以评估对这种致盲性,多因素疾病的易感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号